Deep Phenotyping of Pathology‐Confirmed Benign Lesions in PTEN Hamartoma Tumor Syndrome Patients
Authors:
- Ane J. Schei‐AndersenASAne J. Schei‐Andersen
- Janneke H. M. Schuurs‐HoeijmakersJSJanneke H. M. Schuurs‐Hoeijmakers
- Rachel van der PostRPRachel van der Post
- Arjen R. MensenkampAMArjen R. Mensenkamp
- Jolanda SchievingJSJolanda Schieving
- PTEN Study GroupPGPTEN Study Group
- Janet R. VosJVJanet R. Vos
- Nicoline HoogerbruggeNHNicoline Hoogerbrugge
Open Access
- 28 April 2025
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 108 (4) , 400-411
Abstract
PTEN Hamartoma Tumor Syndrome (PHTS) is a rare hereditary syndrome. PHTS has a variable phenotype characterized by benign lesions and increased cancer risks. Clarifying the extent of the benign phenotype could facilitate early recognition of PHTS patients before cancer development. Therefore, we assessed the spectrum, frequency, and age of excerpt of pathology‐confirmed benign lesions in PHTS patients. Pathology reports were collected for 379 patients with a pathogenic PTEN variant from the Dutch nationwide pathology databank (Palga). Benign lesions were classified as PHTS‐related based on current clinical diagnostic guidelines and non‐PHTS‐related lesions by ICD‐10 codes. Age of last follow‐up was year of pathology request minus birth year. Analyses were stratified by sex and index status. Patients presented mainly with gastrointestinal (54%), skin (47%), thyroid (31%) and vascular lesions (26%). Males developed lipomas at an early age (9 years (5–34)). Females developed endometrial hyperplasia (16%) at an earlier age (41 years (35–49)) and uterine polyps (13%) more often than the general population. No significant differences were observed between sexes or index and non‐index patients. The results are reflective of current diagnostic guidelines. Early‐onset lipomas may be useful for early detection of PHTS patients. Additionally, uterine polyps should be considered for inclusion as a PHTS‐related lesion.Keywords
Funding Information
- HORIZON EUROPE Marie Sklodowska-Curie Actions
This publication has 31 references indexed in Scilit:
- Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for improved recognition: A single‐center studyInternational Journal of Cancer, 2024
- Yield of annual endometrial cancer surveillance in women with PTEN Hamartoma Tumor SyndromeEuropean Journal of Medical Genetics, 2023
- Genotype-phenotype associations in a large PTEN Hamartoma Tumor Syndrome (PHTS) patient cohortEuropean Journal of Medical Genetics, 2022
- The yield and effectiveness of breast cancer surveillance in women with PTEN Hamartoma Tumor SyndromeCancer, 2022
- Red flags for early recognition of adult patients with PTEN Hamartoma Tumour SyndromeEuropean Journal of Medical Genetics, 2021
- A Clinical Scoring System for Selection of Patients for PTEN Mutation Testing Is Proposed on the Basis of a Prospective Study of 3042 ProbandsThe American Journal of Human Genetics, 2011
- Cowden syndromeCancer Treatment Reviews, 2010
- Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndromeFamilial Cancer, 2009
- Incidence of endometrial hyperplasiaAmerican Journal of Obstetrics and Gynecology, 2009
- Prevalence of endometrial polyps and abnormal uterine bleeding in a Danish population aged 20–74 yearsUltrasound in Obstetrics & Gynecology, 2008